Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Viruses|March 30, 2023
HSV1716 Prevents Myeloma Cell Regrowth When Combined with Bortezomib In Vitro and Significantly Reduces Systemic Tumor Growth in Mouse ModelsSimon Tazzyman, Georgia R Stewart, James Yeomans, et al.
Plos One|March 14, 2015
NOD/SCID-GAMMA mice are an ideal strain to assess the efficacy of therapeutic agents used in the treatment of myeloma bone diseaseMichelle A Lawson, Julia M Paton-Hough, Holly R Evans, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 16, 2018
Preventing and Repairing Myeloma Bone Disease by Combining Conventional Antiresorptive Treatment With a Bone Anabolic Agent in Murine ModelsJulia Paton-Hough, Simon Tazzyman, Holly Evans, et al.
JBMR Plus|February 22, 2020
Differential Pain-Related Behaviors and Bone Disease in Immunocompetent Mouse Models of MyelomaMarta Diaz-delCastillo, Danna Kamstrup, Rikke Brix Olsen, et al.
Leukemia|April 17, 2025
An oncolytic adenovirus targeting SLAMF7 demonstrates anti-myeloma efficacyGeorgia Stewart, Simon Tazzyman, Yidan Sun, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 24, 2019
TGFβ Inhibition Stimulates Collagen Maturation to Enhance Bone Repair and Fracture Resistance in a Murine Myeloma ModelAlanna C Green, Darren Lath, Katie Hudson, et al.
Molecular Cancer Therapeutics|October 10, 2024
Targeting Tumor Antigen 5T4 Using CAR T Cells for the Treatment of Acute Myeloid LeukemiaRichard Harrop, Daniel G Blount, Naeem Khan, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 7, 2010
Optimal bone strength and mineralization requires the type 2 iodothyronine deiodinase in osteoblastsJ H Duncan Bassett, Alan Boyde, Peter G T Howell, et al.
Journal of Bone Oncology|March 28, 2022
The P2RX7B splice variant modulates osteosarcoma cell behaviour and metastatic propertiesLuke Tattersall, Karan M Shah, Darren L Lath, et al.
Oncogene|June 12, 2020
The E3 ligase HUWE1 inhibition as a therapeutic strategy to target MYC in multiple myelomaLisa J Crawford, David C Campbell, Jonathan J Morgan, et al.
Pageof 3